Back
Cheche Group, Inc. Vs. Novo Nordisk A/S Industry Stock Comparison
Buy
62
CCG
Cheche Group, Inc.
Last Price:
$0.90
Seasonality Move:
-57.21%
Sell
27
NVO
Novo Nordisk A/S
Last Price:
$36.97
Seasonality Move:
12.55%
Buy
62
Cheche Group, Inc. (CCG)
is a Buy
Is Cheche Group, Inc. a Buy, Sell or Hold?
-
The current Cheche Group, Inc. [CCG] share price is $0.89. The Score for CCG is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
-
CCG is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
27
Novo Nordisk A/S (NVO)
is a Sell
Is Novo Nordisk A/S a Buy, Sell or Hold?
-
The current Novo Nordisk A/S [NVO] share price is $36.98. The Score for NVO is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
-
NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CCG Stock Price Chart
What is Cheche Group, Inc.'s stock price today?
-
The Cheche Group, Inc. share price today is $0.89Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CCG is experiencing slight buying pressure.
NVO Stock Price Chart
What is Novo Nordisk A/S's stock price today?
-
The Novo Nordisk A/S share price today is $36.98Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing buying pressure, which is a positive indicator for future bullish movement.
CCG Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.02 | Buy |
| Relative Strength Index (14 RSI): | 67.55 | Buy |
| Chaikin Money Flow: | 46121 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.76 - 0.84) | Buy |
| Bollinger Bands (100): | (0.78 - 0.92) | Buy |
NVO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.87 | Sell |
| Relative Strength Index (14 RSI): | 39.83 | Sell |
| Chaikin Money Flow: | 14566902 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (36.41 - 38.59) | Sell |
| Bollinger Bands (100): | (39.84 - 55.48) | Sell |
CCG Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.82 | Buy |
| 20-day SMA: | 0.8 | Buy |
| 50-day SMA: | 0.8 | Buy |
| 200-day SMA: | 0.91 | Sell |
| 8-day EMA: | 0.84 | Buy |
| 20-day EMA: | 0.81 | Buy |
| 50-day EMA: | 0.81 | Buy |
| 200-day EMA: | 0.93 | Sell |
NVO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 36.4 | Buy |
| 20-day SMA: | 37.4 | Sell |
| 50-day SMA: | 44.19 | Sell |
| 200-day SMA: | 53.09 | Sell |
| 8-day EMA: | 36.61 | Buy |
| 20-day EMA: | 37.8 | Sell |
| 50-day EMA: | 42.18 | Sell |
| 200-day EMA: | 54.43 | Sell |
Cheche Group, Inc. Earnings Growth & CCG Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.05 per share, and a decrease next year of $0.00 per share.
Novo Nordisk A/S Earnings Growth & NVO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.29 per share, and an increase next year of $0.05 per share.
Cheche Group, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Novo Nordisk A/S Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||